John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$510M |
| 2 |
Broadcom
AVGO
|
+$318M |
| 3 |
Marvell Technology
MRVL
|
+$290M |
| 4 |
Salesforce
CRM
|
+$263M |
| 5 |
Advanced Micro Devices
AMD
|
+$250M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$255M |
| 2 |
Progressive
PGR
|
+$244M |
| 3 |
Visa
V
|
+$238M |
| 4 |
Lam Research
LRCX
|
+$201M |
| 5 |
Elevance Health
ELV
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.88% |
| 2 | Healthcare | 13.28% |
| 3 | Financials | 10.32% |
| 4 | Industrials | 9.79% |
| 5 | Consumer Discretionary | 8.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2701
EQT Corp
EQT
$33.6B
| $261K | ﹤0.01% |
+4,885
| New | +$250K |
|
2702
MainStreet Bancshares
MNSB
$179M
| $259K | ﹤0.01% |
15,464
-324
| -2% | -$5.44K |
|
|
OLPX
2703
DELISTED
Olaplex Holdings
OLPX
| $258K | ﹤0.01% |
203,484
-106,000
| -34% | -$157K |
|
|
FDIQ
2704
Invesco Bloomberg Financial Data Providers ETF
FDIQ
$44.1M
| $258K | ﹤0.01% |
+4,600
| New | +$276K |
|
|
CVGW
2705
DELISTED
Calavo Growers
CVGW
| $257K | ﹤0.01% |
10,724
-42,490
| -80% | -$998K |
|
2706
Solid Biosciences
SLDB
$982M
| $257K | ﹤0.01% |
69,494
-66,651
| -49% | -$285K |
|
2707
Newmark Group
NMRK
$2.91B
| $257K | ﹤0.01% |
21,119
-1,304
| -6% | -$17.4K |
|
2708
NextDecade
NEXT
$1.96B
| $256K | ﹤0.01% |
32,949
+88
| +0.3% | +$710 |
|
2709
Unilever
UL
$141B
| $256K | ﹤0.01% |
3,821
-151,908
| -98% | -$9.8M |
|
2710
Acumen Pharmaceuticals
ABOS
$223M
| $256K | ﹤0.01% |
232,293
-68,975
| -23% | -$98.5K |
|
|
SEZL
2711
Sezzle
SEZL
$3.97B
| $255K | ﹤0.01% |
7,303
-2,927
| -29% | -$124K |
|
|
BBNX
2712
Beta Bionics
BBNX
$888M
| $254K | ﹤0.01% |
+20,751
| New | +$387K |
|
|
WSR
2713
DELISTED
Whitestone REIT
WSR
| $254K | ﹤0.01% |
+17,405
| New | +$240K |
|
2714
Gilat Satellite Networks
GILT
$766M
| $253K | ﹤0.01% |
39,897
-104,222
| -72% | -$724K |
|
|
LUXE
2715
LuxExperience B.V.
LUXE
$1.07B
| $253K | ﹤0.01% |
33,469
+11,307
| +51% | +$105K |
|
2716
International Bancshares
IBOC
$4.45B
| $253K | ﹤0.01% |
+4,010
| New | +$259K |
|
|
SFBS
2717
ServisFirst Bancshares
SFBS
$4.8B
| $252K | ﹤0.01% |
6,108
-20
| -0.3% | -$869 |
|
|
PRSU
2718
Pursuit Attractions and Hospitality Inc
PRSU
$1.33B
| $251K | ﹤0.01% |
7,093
-23,759
| -77% | -$928K |
|
2719
UNIFI
UFI
$142M
| $251K | ﹤0.01% |
52,092
-44,022
| -46% | -$247K |
|
|
MBX
2720
MBX Biosciences
MBX
$3.2B
| $250K | ﹤0.01% |
+33,833
| New | +$358K |
|
2721
Annovis Bio
ANVS
$74.6M
| $249K | ﹤0.01% |
166,219
+155,296
| +1,422% | +$475K |
|
2722
Adecoagro
AGRO
$1.62B
| $248K | ﹤0.01% |
22,161
-73,590
| -77% | -$755K |
|
2723
Invesco Biotechnology & Genome ETF
PBE
$401M
| $247K | ﹤0.01% |
3,900
-200
| -5% | -$13.5K |
|
|
HITI
2724
High Tide
HITI
$216M
| $246K | ﹤0.01% |
130,389
-180,915
| -58% | -$477K |
|
2725
Oak Valley Bancorp
OVLY
$289M
| $245K | ﹤0.01% |
9,798
-674
| -6% | -$17.6K |
|
Similar funds
John Overdeck's Q1 2025 Portfolio in Review
As of Q1 2025, John Overdeck held 3,617 positions worth $46.8B, up 2% from $45.9B the previous quarter. Its ten largest holdings account for 8.1% of the portfolio.
John Overdeck deployed $2.08B of net new capital in Q1 2025, opening 458 new positions and adding to 1,225 existing holdings. Its largest new stake was Advanced Micro Devices: 2,246,952 shares worth $231M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Eli Lilly, an estimated $255M trimmed.
- John Overdeck's largest Q1 2025 buy was Advanced Micro Devices: 2,246,952 shares worth $231M.
- John Overdeck added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $510M increase.
- John Overdeck's biggest Q1 2025 reduction was Eli Lilly, cutting an estimated $255M.
- John Overdeck fully exited Coinbase in Q1 2025, selling an estimated $45M.
- John Overdeck's ten largest holdings make up 8.1% of its $46.8B portfolio in Q1 2025.
- John Overdeck opened 458 new positions and closed 452 in Q1 2025.
- John Overdeck's portfolio value rose 2% quarter-over-quarter to $46.8B.
Based on Two Sigma Investments's 13F filing for Q1 2025, filed 15 May 2025.